6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

“…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

“…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”

Effects of finerenone on the urinary β2-MG levels in all patients. by Jia Song (495396)

The RehaGait® system. by Johanna Rydja (12300797)

“…Step height was normalized postoperatively; all other variables remained significantly worse than the HI. …”

Flow chart of included patients and dropouts. by Johanna Rydja (12300797)

“…Step height was normalized postoperatively; all other variables remained significantly worse than the HI. …”

Dataset of the analyzed data. by Johanna Rydja (12300797)

“…Step height was normalized postoperatively; all other variables remained significantly worse than the HI. …”

Time series comparing trends at HSJ and control hospitals in the pre-intervention and intervention period. Significance test determine if trends differ between groups. by Eva Rydahl (6260771)

Subjects:

Participant characteristics. by Ronald Kusolo (13200268)

Subjects:

Reason for exclusion of all 6514 screened articles. by Solima Sabeel (9545738)

This file contains the complete dataset analyzed in the current study, including all variables used for statistical modeling. by Jung-Tae Kim (8997767)

Participant characteristics, overall and for each transition, of primary analytic sample (activity data for all 14 days of the respective transition period). by Shelby L. Sturrock (10751675)

Supporting datasets for all figures. by Matthew Drill (22258391)

“…Inhibition of P2X7R with small molecule antagonist AZ10606120, for 72 hours significantly decreased U251 cell number (p < 0.0001), and significantly increased tumour cell death, as evidenced by increased LDH release (p < 0.001). …”

The linearly decreasing convergence factor a. by Junhao Wei (6816803)

Molecular docking showed that ABT-199 can fit into active site of ALK^Mutant. by Richard Junior Zapata Dongo (17912565)

S1 Data - by Richard Junior Zapata Dongo (17912565)

“…This interaction was further supported by a significant decrease of ALK phosphorylation in single and combination treatment with 300nM ABT-199. …”

Estimates of the average yearly citations per publication (including all publications) by scholar group, misconduct type, and time. by Giulia Maimone (20833354)

Multiple distinct outcomes observed in soft-shell clams (<i>Mya arenaria</i>) after natural infection with MarBTN. by Rachael M. Giersch (22331947)

MarBTN-specific eDNA detection in each clam that was followed for MarBTN in hemolymph and eDNA. by Rachael M. Giersch (22331947)

Summary of significant single-arm time effect. by Wensheng Xiao (16557866)

Data_table_with_all_identified_articles_31-JAN-2025. by Renáta Kiss-Miki (20760127)